SHIMOJANI
Shimojani LLC is a San Francisco-based company founded to validate and commercialize agents with the therapeutic potential to reduce or prevent hemorrhagic conversion in ischemic stroke patients.
SHIMOJANI
Industry:
Biotechnology
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.shimojani.com
Status:
Active
Contact:
650-735-1173
Email Addresses:
[email protected]
Technology used in webpage:
SSL By Default Google Analytics LetsEncrypt Nginx Amazon Google Apps For Business Amazon Virginia Region Google Analytics Classic Nginx 1.14 Google DNS
Similar Organizations
ChemGen
ChemGen Corp., a privately held bioscience company.
Current Employees Featured
Official Site Inspections
http://www.shimojani.com
- Host name: 172.67.153.150
- IP address: 172.67.153.150
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Shimojani"
Shimojani
Shimojani ... NewsSee details»
Shimojani - Crunchbase Company Profile & Funding
Organization. Shimojani . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... Shimojani LLC is a San Francisco-based company …See details»
Shimojani Company Profile 2024: Valuation, Funding & Investors
Who is the founder of Shimojani? Susan Clymer and Lawrence Kauvar Ph.D are the founders of Shimojani. Where is Shimojani headquartered? Shimojani is headquartered in Pray, MT. What …See details»
Shimojani - Ownership and Business Overview - Mergr
Shimojani is a biotech company and founded to validate and commercialize agents with the therapeutic potential to reduce or prevent hemorrhagic conversion in ischemic stroke patients. …See details»
Shimojani Financial Overview, Employee Count, and Competitors
Shimojani LLC is a San Francisco-based company founded to validate and commercialize agents with the therapeutic potential to reduce or prevent hemorrhagic conversion in ischemic stroke …See details»
Shimojani - Contacts, Employees, Board Members, Advisors
Organization. Shimojani . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. Shimojani has 1 current …See details»
Shimojani LLC :: Montana (US) :: OpenCorporates
Jan 10, 2023 Free and open company data on Montana (US) company Shimojani LLC (company number C1215776)See details»
SHIMOJANI, INC. in Wilmington, DE | Company Info & Reviews
Nov 12, 2024 SHIMOJANI, INC. is a Delaware Corporation filed on March 5, 2012. The company's File Number is listed as 5118895 . The Registered Agent on file for this company is …See details»
Shimojani LLC | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Shimojani LLC - BioCentury Company Profiles - BCIQ
Mar 4, 2013 Shimojani LLC - BioCentury Company Profiles for the biopharma industrySee details»
Shimojani Licenses New Stroke Therapy from Niigata University
Shimojani co-founder and Vice President Larry Kauvar commented, .The fundamental advance by Dr. Shimohata was to identify a signal transduction pathway that plays a key role in …See details»
Shimojani Licenses New Stroke Therapy from Niigata University
Feb 22, 2013 Shimojani Licenses New Stroke Therapy from Niigata University Shimojani to Advance Program into IND-enabling Studies SAN FRANCISCO--(BUSINESS WIRE)-- …See details»
Patents Assigned to Shimojani, LLC - Justia Patents Search
Aug 2, 2021 Abstract: Treatment of subjects experiencing cerebral ischemia is improved when the treatment employs a thrombolytic and an inhibitor against vascular endothelial growth …See details»
Takayoshi Shimohata - Academic Advisor - ShimoJani LLC | LinkedIn
Academic Advisor - ShimoJani LLC · Specialties: 神経内科学を専門にしています．とくに脳虚血や低血糖脳症に対する新規治療薬の開発，および多系統萎縮症などの神経変性疾患の治療， …See details»
Takayoshi Shimohata - Academic Advisor - ShimoJani LLC | LinkedIn
Associate professor, Brain Research Institute, Niigata University · Specialties: 神経内科学を専門にしています．とくに脳虚血や低血糖脳症に対する新規治療薬の開発，および多系統萎縮症 …See details»
脳梗塞に対する創薬ベンチャーShimoJani LLCの状況報告です．
Dec 6, 2017 私たちは脳梗塞に対する血栓溶解療法後の脳出血合併症の防止を目的として，tPAと抗VEGF（血管内皮増殖因子）抗体の併用による血管保護療法が可能であることを …See details»
Research programme: antihaemorhhagics - Niigata …
Shimojani, a private biotech company and Niigata University are developing novel small molecule and protein compounds to inhibit haemorrhage following Research programme: …See details»
Shimojani Licenses New Stroke Therapy from Niigata University
Shimojani LLC, a privately held biotech company, today announced that it has acquired an exclusive license from Niigata University for worldwide development and commercialization …See details»
Takayoshi Shimohata - Academic Advisor @ Shimojani - Crunchbase
Takayoshi Shimohata is the Academic Advisor at Shimojani. Takayoshi attended Niigata University. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. …See details»
DRUG REGIMEN FOR TREATMENT OF CEREBRAL ISCHEMIA
Aug 2, 2021 Treatment of subjects experiencing cerebral ischemia is improved when the treatment employs a thrombolytic and an inhibitor against vascular endothelial growth factor …See details»